Showing results (2741-2750 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|July 22, 2026
A Phase II Study to Evaluate the Efficacy of Commercially Available Molecularly Matched Targeted Therapies in the Second-Line SettingSuzanne Jones, Gerald Falchook, Stephanie Graff, et al.
The Oncologist|June 23, 2026
Beyond the Binary: A Nationwide Study of Physician Decision Orientations Toward Artificial Hydration in Terminal Cancer CareChien-Yi Wu, Jui-Han Yang, Chih-Yuan Shih, et al.
The Oncologist|June 23, 2026
Genomic Determinants and an Exploratory Prognostic Model for Immunotherapy Outcomes in Recurrent or Metastatic Cervical CancerLingling Gu, Biqing Zhu, Cuicui Liu, et al.
The Oncologist|July 6, 2026
Durable Response to Sotorasib in KRAS G12C-Mutant Intrahepatic Cholangiocarcinoma: A Case ReportChaoxing Liu, Kang Li, Jingjian Feng
The Oncologist|July 3, 2026
Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 populationNinna Aggerholm-Pedersen, Mette Møller Handrup, Stine Bogestofte Thomassen, et al.
The Oncologist|July 13, 2026
Risk of venous thromboembolism with CDK 4/6 inhibitor use in breast cancer: A systematic review and meta-analysisElysa Cortez, Erick Torres Luna, Marcos Blancarte Ibarra, et al.
The Oncologist|July 13, 2026
Selinexor plus tislelizumab in patients with relapsed/refractory NK/T-cell lymphoma after failure of PD-1 blockade: the phase 1b TOUCH trialChuanxu Liu, Dahui Li, Yan Gao, et al.
The Oncologist|July 11, 2026
The use of antibiotic, probiotic, and FMT in modulating Immunotherapy Efficacy and Survival: a systematic review and meta-analysis of clinical outcomesZijun Zhai, Shuling Ma, Shijie Shang, et al.
The Oncologist|March 19, 2026
Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selectionLetizia Procaccio, Guido Giordano, Federico Nichetti, et al.
The Oncologist|April 19, 2026
Trends in Primary Surgery and Overall Survival in Non-Metastatic Anal Cancer: A Population-Based AnalysisChan Shen, Madison Conces, Kristen Ciombor, et al.
Pageof 571